The EBiSC team is working hard to implement improvements in how EBiSC operates. Due to some short-term disruption, please get in touch via Contact@EBiSC.org if the cells you would like to access are currently listed as unavailable or you are ordering from outside of Europe.

STBCi322-A-7

HNF1A-MODY mutation in STBCi322-A-1 NKX6.1-GFP reporter line.

Gene-edited iPSC line

Not released.
We are currently making some changes to how EBiSC operates and because of this there is a short period of time where orders cannot be placed.

If you are interested in accessing these cells, please contact EBiSC directly. For more information about the current transition process see here.
The cell line is not released.
(only basic data is shown)

General#

Cell Line

hPSCreg name STBCi322-A-7
Alternative name(s)
HNF1A-MODY mutation in STBCi322-A-1 NKX6.1-GFP reporter line.
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Notes HNF1A KO in NKX1.6-GFP reporter cell line (STBCi322-A-1)

Provider

Depositor AstraZeneca AB (AZ)
Distributors
EBiSC

External Databases

hPSCreg STBCi322-A-7

General Information

This EBiSC line can be used for:
Yes
Research use: allowed
Clinical use: no
Commercial use: no
Subclone of (not in EBiSC, see STBCi322-A in hPSCreg)

hIPSC Derivation#

General

More source cell information can be found in the parental cell line STBCi322-A in hPSCreg.